CytoMed Therapeutics Limited
Last updated September 27, 2026
Organization details
- Legal name
- CytoMed Therapeutics Limited
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Singapore
- Headquarters city
- 1 Commonwealth Lane
- Headquarters country
- Singapore
- Fiscal year end
- December
- Ticker symbol
- GDTC
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001873093
Board of directors
-
Chak Hua Yew · DirectorSince 2023
-
Chee Kong Choo · DirectorSince 2023
-
Jieming Zeng · Director · CSO and CMOSince 2023
-
Keng Kiat Toh · DirectorSince 2023
-
Lucas Tien Wee Luk · Director · Chief Clinical OfficerSince 2023
-
Mark Kei Wei Leong · DirectorSince 2023
-
Wee Kiat Tan · Director · Chief Operating OfficerSince 2023
-
Yuin Han Loh · DirectorSince 2023
Board connections
1 of this board's directors also sit on 1 other board.
- via Chak Hua Yew
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $428,800
- 3 purchases by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 20, 2026 | Chee Kong Choo Director, 10% owner | Open-market purchase | −100,000 | $1.50 | $150,000 |
| Jul 14, 2026 | Chee Kong Choo Director, 10% owner | Open-market purchase | −100,000 | $1.50 | $150,000 |
| May 13, 2026 | Chee Kong Choo Director, 10% owner | Open-market purchase | +112,000 | $1.15 | $128,800 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.